Associated Papers
Genomic subtypes of non-muscle-invasive bladder cancer: guiding immunotherapy decision-making for patients exposed to aristolochic acid.
Peng Y et al.
Molecular Medicine (cambridge, Mass.), 2025
40247187 (PubMed )
Supplement: 10020_2025_1199_MOESM5_ESM.xlsx › Sheet1
Exploring FGFR3 Mutations in the Male Germline: Implications for Clonal Germline Expansions and Paternal Age-Related Dysplasias.
Moura S et al.
Genome Biology and Evolution, 2024
Clinical and genomic features of Chinese lung cancer patients with germline mutations.
Peng W et al.
Nature Communications, 2022
35273153 (PubMed )
Supplement: 41467_2022_28840_MOESM7_ESM.xlsx › Sheet1
Discovery of an unusually high number of de novo mutations in sperm of older men using duplex sequencing.
Salazar R et al.
Genome Research, 2022
Insights of fibroblast growth factor receptor 3 aberrations in pan-cancer and their roles in potential clinical treatment.
Li J et al.
Aging, 2021
34160364 (PubMed )
Supplement: aging-13-203175-s003.xlsx › ___1
Germline Variants of Prostate Cancer in Japanese Families.
Hayano T et al.
Plos One, 2016
Select a paper to view details